Evidence map›Paper›PMID 37266374›Full record

ArticleFrontiers in molecular neuroscience2023

Alzheimer's disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs.

Karol Andrea Arizaca Maquera, Justin Ralph Welden, Giorgi Margvelani, Sandra C Miranda Sardón, Samantha Hart, Noémie Robil, Alvaro Gonzalo Hernandez, Pierre de la Grange, Peter T Nelson, Stefan Stamm

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Translation of circular RNAs.Nucleic acids research · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Widespread transposable element dysregulation in human aging brains with Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Karol Andrea Arizaca MaqueraDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, United States.
Justin Ralph WeldenSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States.
Giorgi MargvelaniDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, United States.
Sandra C Miranda SardónDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, United States.
Samantha HartDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, United States.
Noémie RobilGenoSplice, Paris, France.
Alvaro Gonzalo HernandezDNA Services Facility, University of Illinois, Urbana, IL, United States.
Pierre de la GrangeGenoSplice, Paris, France.
Peter T NelsonSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States.
Stefan StammDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, United States.
University of Kentucky · USUrbana University · US

Funding

University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Training in Translational Research in Alzheimer's and Related Dementias (TRIAD)T32AG078110 · NIA · UNIVERSITY OF KENTUCKY · PI Michael Paul Murphy, LINDA J VAN ELDIK · 2022 to 2026
$2.3M
NIA NIH HHS P30 AG072946NIA NIH HHS T32 AG078110
6 · The paper itself

Abstract

Introduction: The molecular changes leading to Alzheimer's disease (AD) progression are poorly understood. A decisive factor in the disease occurs when neurofibrillary tangles (NFT) composed of microtubule associated protein tau (MAPT) form in the entorhinal cortex and then spread throughout the brain. Methods: We therefore determined mRNA and circular RNA changes during AD progression, comparing Braak NFT stages I-VI. Total RNA was isolated from human brain (entorhinal and frontotemporal cortex). Poly(A)+ RNA was subjected to Nanopore sequencing, and total RNA was analyzed by standard Illumina sequencing. Circular RNAs were sequenced from RNase R treated and rRNA depleted total RNA. The sequences were analyzed using different bioinformatic tools, and expression constructs for circRNAs were analyzed in transfection experiments. Results: We detected 11,873 circRNAs of which 276 correlated with Braak NFT stages. Adenosine to inosine RNA editing increased about threefold in circRNAs during AD progression. Importantly, this correlation cannot be detected with mRNAs. CircMAN2A1 expression correlated with AD progression and transfection experiments indicated that RNA editing promoted its translation using start codons out of frame with linear mRNAs, which generates novel proteins. Discussion: Thus, we identified novel regulated retained introns that correlate with NFT Braak stages and provide evidence for a role of translated circRNAs in AD development.

Indexed as

alternative splicingAlzheimerBraak stagecircular RNAsgene expressionretained intron

Identifiers

PMID37266374
PMCPMC10231643
OpenAlexW4376959020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.